Increasing use of dose-escalated external beam radiation therapy for men with nonmetastatic prostate cancer

International Journal of Radiation Oncology Biology Physics

Volumn 89, Issue 1, 2014, Pages 103-112

  Swisher Mcclure, Samuel ^a,b   Mitra, Nandita ^b   Woo, Kaitlin ^b   Smaldone, Marc ^c   Uzzo, Robert ^c   Bekelman, Justin E ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c TEMPLE UNIVERSITY HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSIS; DISEASES;

CLINICAL PRACTICES; DEMOGRAPHIC CHARACTERISTICS; EXTERNAL BEAM RADIATION THERAPY; INTENSITY MODULATED RADIATION THERAPY; LOGISTIC REGRESSIONS; METHODS AND MATERIALS; MULTIVARIABLE ANALYSIS; RADIATION ONCOLOGISTS;

RADIOTHERAPY;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CLINICAL PRACTICE; DEMOGRAPHY; EXTERNAL BEAM RADIOTHERAPY; GLEASON SCORE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE ESCALATION; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; DATABASES, FACTUAL; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NEOPLASM GRADING; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, INTENSITY-MODULATED; REGISTRIES; RETROSPECTIVE STUDIES; RISK; TIME FACTORS; UNITED STATES;

EID: 84898630528     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2014.01.050     Document Type: Article

References (27)

1. G.A. Viani, E.J. Stefano, and S.L. Afonso Higher-than-conventional radiation doses in localized prostate cancer treatment: A meta-analysis of randomized, controlled trials Int J Radiat Oncol Biol Phys 74 2009 1405 1418
2. A.L. Zietman, K. Bae, and J.D. Slater et al. Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: Long-term results from Proton Radiation Oncology Group/American College of Radiology 95-09 J Clin Oncol 28 2010 1106 1111
3. D.A. Kuban, S.L. Tucker, and L. Dong et al. Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer Int J Radiat Oncol Biol Phys 70 2008 67 74 (Pubitemid 350251041)
4. D.P. Dearnaley, M.R. Sydes, and J.D. Graham et al. Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: First results from the MRC RT01 randomised controlled trial Lancet Oncol 8 2007 475 487 (Pubitemid 46805903)
5. S.T. Peeters, W.D. Heemsbergen, and P.C. Koper et al. Dose-response in radiotherapy for localized prostate cancer: Results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy J Clin Oncol 24 2006 1990 1996 (Pubitemid 46622106)
6. W.U. Shipley, L.J. Verhey, and J.E. Munzenrider et al. Advanced prostate cancer: The results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone Int J Radiat Oncol Biol Phys 32 1995 3 12
7. J.R. Sathya, I.R. Davis, and J.A. Julian et al. Randomized trial comparing iridium implant plus external-beam radiation therapy with external-beam radiation therapy alone in node-negative locally advanced cancer of the prostate J Clin Oncol 23 2005 1192 1199 (Pubitemid 46202276)
8. A.L. Zietman, M.L. DeSilvio, and J.D. Slater et al. Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: A randomized controlled trial JAMA 294 2005 1233 1239 (Pubitemid 41352111)
9. A. Pollack, G.K. Zagars, and G. Starkschall et al. Prostate cancer radiation dose response: Results of the M. D. Anderson phase III randomized trial Int J Radiat Oncol Biol Phys 53 2002 1097 1105 (Pubitemid 34787842)
10. J. Mohler, R.R. Bahnson, and B. Boston et al. NCCN clinical practice guidelines in oncology: Prostate cancer J Natl Compr Canc Netw 8 2010 162 200
11. National Comprehensive Cancer Network. Clinical practice guidelines in oncology: Prostate cancer. 2003-2010. Available at: http://www.nccn.org. Accessed February 12, 2013.
12. Quality Research in Radiation Oncology Genitourinary Committee. QRRO clinical performance measures. Available at: http://www.qrro.org/Prostate-CPM. pdf. Accessed May 17, 2013.
13. A. Bill-Axelson, L. Holmberg, and M. Ruutu et al. Radical prostatectomy versus watchful waiting in early prostate cancer N Engl J Med 364 2011 1708 1717
14. T.J. Wilt, M.K. Brawer, and K.M. Jones et al. Radical prostatectomy versus observation for localized prostate cancer N Engl J Med 367 2012 203 213
15. M.J. Zelefsky, J. Moughan, and J. Owen et al. Changing trends in national practice for external beam radiotherapy for clinically localized prostate cancer: 1999 Patterns of Care survey for prostate cancer Int J Radiat Oncol Biol Phys 59 2004 1053 1061 (Pubitemid 38834298)
16. M.J. Zelefsky, W.R. Lee, and A. Zietman et al. Evaluation of adherence to quality measures for prostate cancer radiotherapy in the United States: Results from the Quality Research in Radiation Oncology (QRRO) survey Pract Radiat Oncol 3 2013 2 8
17. American College of Surgeons Commission on Cancer. National Cancer Data Base. Available at: http://www.facs.org/cancer/ncdb/index.html. Accessed March 4, 2013.
18. R.A. Deyo, D.C. Cherkin, and M.A. Ciol Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases J Clin Epidemiol 45 1992 613 619
19. C.B. Begg, E.R. Riedel, and P.B. Bach et al. Variations in morbidity after radical prostatectomy N Engl J Med 346 2002 1138 1144 (Pubitemid 34984605)
20. D. Schrag, L.D. Cramer, and P.B. Bach et al. Influence of hospital procedure volume on outcomes following surgery for colon cancer JAMA 284 2000 3028 3035 (Pubitemid 32014740)
21. K.Y. Bilimoria, D.J. Bentrem, and J.M. Feinglass et al. Directing surgical quality improvement initiatives: Comparison of perioperative mortality and long-term survival for cancer surgery J Clin Oncol 26 2008 4626 4633
22. A.Y. Chen, S. Fedewa, and A. Pavluck et al. Improved survival is associated with treatment at high-volume teaching facilities for patients with advanced stage laryngeal cancer Cancer 116 2010 4744 4752
23. K.Y. Bilimoria, D.J. Bentrem, and A.K. Stewart et al. Lymph node evaluation as a colon cancer quality measure: A national hospital report card J Natl Cancer Inst 100 2008 1310 1317
24. C.E. Pollack, J.E. Bekelman, and A.J. Epstein et al. Racial disparities in changing to a high-volume urologist among men with localized prostate cancer Med Care 49 2011 999 1006
25. D.A. Kuban, L.B. Levy, and M.R. Cheung et al. Long-term failure patterns and survival in a randomized dose-escalation trial for prostate cancer. Who dies of disease? Int J Radiat Oncol Biol Phys 79 2011 1310 1317
26. Radiation Therapy Oncology Group 0126. A phase III randomized study of high dose 3D-CRT/IMRT versus standard dose 3D-CRT/IMRT in patients treated for localized prostate cancer. Available at: http://www.rtog.org. Accessed July 24, 2013.
27. K.Y. Bilimoria, D.J. Bentrem, and A.K. Stewart et al. Comparison of Commission on Cancer-approved and -nonapproved hospitals in the United States: Implications for studies that use the National Cancer Data Base J Clin Oncol 27 2009 4177 4181